Ayaka Endo
Research Subjects
Research Interests
Ayaka Endo has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Akio Kawamura
Division of Cardiology, Department of Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan
2 shared publications Haruaki Nakaya
Chiba University
1 shared publicationHideo Mitamura
Saiseikai Central Hospital
1 shared publicationHirotsugu Atarashi
Nippon Medical School
1 shared publicationJ-RHYTHM Investigators
1 shared publication- Keiichi Fukuda
Department of Cardiology, Keio University School of Medicine, Tokyo, Japan
1 shared publication
Latest Publications
- 1 June 2012
- Vol. 24 (6) , E115-8
Left main trunk perforation sealed by 90 second perfusion balloon inflation.
Coronary perforation is a rare but serious complication of percutaneous coronary intervention. In our case, kissing balloon technique caused the perforation. We took care of balloon diameter and inflation pressure, but we did not consider that the proximal lumen could take elliptical rather than circular shape. Then perforation occurred at the proximal side of the kissing balloon technique. Fortunately, we could achieve hemostasis successfully by 90 seconds perfusion balloon inflation. You must consider not only balloon diameter and inflation pressure but also balloon form as an important safety factor for the kissing balloon technique on the left main trunk.
- 1 June 2012
- Vol. 24 (6) , E115-8
Left main trunk perforation sealed by 90 second perfusion balloon inflation.
Coronary perforation is a rare but serious complication of percutaneous coronary intervention. In our case, kissing balloon technique caused the perforation. We took care of balloon diameter and inflation pressure, but we did not consider that the proximal lumen could take elliptical rather than circular shape. Then perforation occurred at the proximal side of the kissing balloon technique. Fortunately, we could achieve hemostasis successfully by 90 seconds perfusion balloon inflation. You must consider not only balloon diameter and inflation pressure but also balloon form as an important safety factor for the kissing balloon technique on the left main trunk.
- 7 July 2011
- Published by Springer Nature in Heart and Vessels
- Vol. 27 (3) , 331-336
Successful percutaneous coil embolization of coronary–pulmonary, –carotid, and –internal mammary artery fistulas
We herein describe a 57-year-old man with coronary–pulmonary artery fistulas that had abnormal connections between the left common carotid artery and the left internal mammary artery. The patient was treated with percutaneous coil embolization using antegrade (via the coronary artery) and retrograde (via the pulmonary artery) approaches. Coronary artery fistulas have diverse anatomical variations, and it is important to thoroughly evaluate the anatomy before beginning any mode of treatment, surgical or endovascular. In the case reported herein, multislice computed tomography played a pivotal role in the preprocedure evaluation.
- 7 July 2011
- Published by Springer Nature in Heart and Vessels
- Vol. 27 (3) , 331-336
Successful percutaneous coil embolization of coronary–pulmonary, –carotid, and –internal mammary artery fistulas
We herein describe a 57-year-old man with coronary–pulmonary artery fistulas that had abnormal connections between the left common carotid artery and the left internal mammary artery. The patient was treated with percutaneous coil embolization using antegrade (via the coronary artery) and retrograde (via the pulmonary artery) approaches. Coronary artery fistulas have diverse anatomical variations, and it is important to thoroughly evaluate the anatomy before beginning any mode of treatment, surgical or endovascular. In the case reported herein, multislice computed tomography played a pivotal role in the preprocedure evaluation.
- 1 January 2010
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 74 (5) , 870-875
Impact of Drug Alteration to Maintain Rhythm Control in Paroxysmal Atrial Fibrillation - Subanalysis From J-RHYTHM Study -
Background: The Japanese Rhythm Management Trial for Atrial Fibrillation (J-RHYTHM) study showed rhythm control was associated with fewer changes in the assigned treatment strategy compared to rate control in atrial fibrillation (AF). The aim was to describe how antiarrhythmics (AAs) were altered in the rhythm control arm and whether altering AAs would impact long-term outcomes. Methods and Results: Of 390 enrolled patients, 23.5% altered their AAs (drug alteration [DA] group). The hard endpoint (HE) was defined as a composite of death, stroke, embolism, major bleeding or heart failure hospitalization; soft endpoint (SE) was defined physical/psychological disability requiring alteration of treatment strategy. The patients were followed for 1.7 years. No significant difference was noted in the occurrence of HE (4.0% vs 6.5%, P=0.31), but DA-group patients had higher rates of SE (9.3% vs 18.4%, P=0.017) compared to single AA patients. The DA group was also associated with the occurrence of SE after adjustment (HR 1.90, P=0.042). When the DA group was subdivided according to the use of class III drugs or change of drugs between classes, there were no differences in outcomes. Conclusions: The need to change AA was associated with physical/psychological disabilities that seemed not to be relieved simply by changing AAs, and this should be considered as a marker for refractory paroxysmal AF requiring other strategies. (Circ J 2010; 74: 870 - 875)
- 1 January 2010
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 74 (5) , 870-875
Impact of Drug Alteration to Maintain Rhythm Control in Paroxysmal Atrial Fibrillation - Subanalysis From J-RHYTHM Study -
Background: The Japanese Rhythm Management Trial for Atrial Fibrillation (J-RHYTHM) study showed rhythm control was associated with fewer changes in the assigned treatment strategy compared to rate control in atrial fibrillation (AF). The aim was to describe how antiarrhythmics (AAs) were altered in the rhythm control arm and whether altering AAs would impact long-term outcomes. Methods and Results: Of 390 enrolled patients, 23.5% altered their AAs (drug alteration [DA] group). The hard endpoint (HE) was defined as a composite of death, stroke, embolism, major bleeding or heart failure hospitalization; soft endpoint (SE) was defined physical/psychological disability requiring alteration of treatment strategy. The patients were followed for 1.7 years. No significant difference was noted in the occurrence of HE (4.0% vs 6.5%, P=0.31), but DA-group patients had higher rates of SE (9.3% vs 18.4%, P=0.017) compared to single AA patients. The DA group was also associated with the occurrence of SE after adjustment (HR 1.90, P=0.042). When the DA group was subdivided according to the use of class III drugs or change of drugs between classes, there were no differences in outcomes. Conclusions: The need to change AA was associated with physical/psychological disabilities that seemed not to be relieved simply by changing AAs, and this should be considered as a marker for refractory paroxysmal AF requiring other strategies. (Circ J 2010; 74: 870 - 875)